1. Home
  2. WAFDP vs REVBW Comparison

WAFDP vs REVBW Comparison

Compare WAFDP & REVBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAFDP
  • REVBW
  • Stock Information
  • Founded
  • WAFDP N/A
  • REVBW N/A
  • Country
  • WAFDP United States
  • REVBW United States
  • Employees
  • WAFDP 2208
  • REVBW 9
  • Industry
  • WAFDP Major Banks
  • REVBW Biotechnology: Pharmaceutical Preparations
  • Sector
  • WAFDP Finance
  • REVBW Health Care
  • Exchange
  • WAFDP Nasdaq
  • REVBW Nasdaq
  • Market Cap
  • WAFDP N/A
  • REVBW N/A
  • IPO Year
  • WAFDP N/A
  • REVBW 2020
  • Fundamental
  • Price
  • WAFDP $16.73
  • REVBW $0.02
  • Analyst Decision
  • WAFDP
  • REVBW
  • Analyst Count
  • WAFDP 0
  • REVBW 0
  • Target Price
  • WAFDP N/A
  • REVBW N/A
  • AVG Volume (30 Days)
  • WAFDP N/A
  • REVBW N/A
  • Earning Date
  • WAFDP N/A
  • REVBW N/A
  • Dividend Yield
  • WAFDP N/A
  • REVBW N/A
  • EPS Growth
  • WAFDP N/A
  • REVBW N/A
  • EPS
  • WAFDP N/A
  • REVBW N/A
  • Revenue
  • WAFDP N/A
  • REVBW N/A
  • Revenue This Year
  • WAFDP N/A
  • REVBW N/A
  • Revenue Next Year
  • WAFDP N/A
  • REVBW N/A
  • P/E Ratio
  • WAFDP N/A
  • REVBW N/A
  • Revenue Growth
  • WAFDP N/A
  • REVBW N/A
  • 52 Week Low
  • WAFDP N/A
  • REVBW N/A
  • 52 Week High
  • WAFDP N/A
  • REVBW N/A
  • Technical
  • Relative Strength Index (RSI)
  • WAFDP 40.94
  • REVBW N/A
  • Support Level
  • WAFDP $16.55
  • REVBW N/A
  • Resistance Level
  • WAFDP $16.86
  • REVBW N/A
  • Average True Range (ATR)
  • WAFDP 0.26
  • REVBW 0.00
  • MACD
  • WAFDP 0.00
  • REVBW 0.00
  • Stochastic Oscillator
  • WAFDP 6.58
  • REVBW 0.00

About WAFDP WaFd Inc. Depositary Shares

WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.

About REVBW Revelation Biosciences Inc. Warrant

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: